In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Arakis closes £29mm third round

08 Sep 2004

Executive Summary

Specialty pharmaceutical company Arakis Ltd. raised £29mm ($51.5mm) in a third financing round, which was led by Novo AS and Scottish Equity Partners. Additional new investors Scottish Widows Investment Partnership, Finsbury Life Sciences, and Close Finsbury Eurotech participated along with returning shareholders Nomura Phase4 Ventures, 3i, Merlin Biosciences, and MB Venture Capital. Company management and directors also contributed.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By